|
Originally published In Press as doi:10.1074/jbc.M112479200 on March 7, 2002
J. Biol. Chem., Vol. 277, Issue 20, 17389-17396, May 17, 2002
Correlation Between tRNALys3 Aminoacylation and Its
Incorporation into HIV-1*
Hassan
Javanbakht §,
Shan
Cen ,
Karin
Musier-Forsyth¶, and
Lawrence
Kleiman § **
From the Lady Davis Institute for Medical Research
and McGill AIDS Centre, Jewish General Hospital, Departments of
§ Medicine and Microbiology and Immunology, McGill
University, Montreal, Quebec H3T 1E2, Canada and the
¶ Department of Chemistry, University of Minnesota,
Minneapolis, Minnesota 55455
During human immunodeficiency virus type 1 (HIV-1) assembly, tRNALys is selectively packaged
into the virus, where tRNALys3 serves as the primer for
reverse transcription. Lysyl-tRNA synthetase is also selectively
incorporated into HIV-1 and is therefore a strong candidate for being
the signal by which viral proteins interact with tRNALys
isoacceptors. Previously, mutations in the tRNALys3
anticodon have been shown to strongly inhibit the charging of tRNALys3 by lysyl-tRNA synthetase in vitro, and
we show here that in vivo aminoacylation is also inhibited
by anticodon changes. The order of decreasing in vivo
aminoacylation for tRNALys3 anticodon mutants is:
wild-type SUU (where S = mcm5S2U) 100%)
SGU (49%) CGU (40%) SGA (0%) and CGA (0%). We found that the ability of these tRNALys3 anticodon variants to be
aminoacylated in vivo is directly correlated with their
ability to be packaged into HIV-1. These data showed that the anticodon
is a major determinant for tRNALys3 packaging and support
the conclusion that its productive interaction with lysyl-tRNA
synthetase is important for tRNALys3 incorporation
into HIV-1.
*
This work was supported in part by grants from the Canadian
Institutes for Health Research and the American Foundation for AIDS
Research.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Lady Davis Institute
for Medical Research-Jewish General Hospital, 3755 Cote St. Catherine
Rd., Montreal, Quebec H3T 1E2, Canada. Tel.: 514-340-8260; Fax:
514-340-7502; E-mail: lawrence.kleiman@mcgill.ca.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. McCulley and C. D. Morrow
Complementation of Human Immunodeficiency Virus Type 1 Replication by Intracellular Selection of Escherichia coli Formula Supplied in trans
J. Virol.,
October 1, 2006;
80(19):
9641 - 9650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Halwani, S. Cen, H. Javanbakht, J. Saadatmand, S. Kim, K. Shiba, and L. Kleiman
Cellular Distribution of Lysyl-tRNA Synthetase and Its Interaction with Gag during Human Immunodeficiency Virus Type 1 Assembly
J. Virol.,
July 15, 2004;
78(14):
7553 - 7564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cen, H. Javanbakht, M. Niu, and L. Kleiman
Ability of Wild-Type and Mutant Lysyl-tRNA Synthetase To Facilitate tRNALys Incorporation into Human Immunodeficiency Virus Type 1
J. Virol.,
February 1, 2004;
78(3):
1595 - 1601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Guo, S. Cen, M. Niu, H. Javanbakht, and L. Kleiman
Specific Inhibition of the Synthesis of Human Lysyl-tRNA Synthetase Results in Decreases in tRNALys Incorporation, tRNA3LysAnnealing to Viral RNA, and Viral Infectivity in Human Immunodeficiency Virus Type 1
J. Virol.,
September 15, 2003;
77(18):
9817 - 9822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Kelly, M. T. Palmer, and C. D. Morrow
Selection of Retroviral Reverse Transcription Primer Is Coordinated with tRNA Biogenesis
J. Virol.,
August 15, 2003;
77(16):
8695 - 8701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Javanbakht, R. Halwani, S. Cen, J. Saadatmand, K. Musier-Forsyth, H. Gottlinger, and L. Kleiman
The Interaction between HIV-1 Gag and Human Lysyl-tRNA Synthetase during Viral Assembly
J. Biol. Chem.,
July 18, 2003;
278(30):
27644 - 27651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Francin and M. Mirande
Functional Dissection of the Eukaryotic-specific tRNA-interacting Factor of Lysyl-tRNA Synthetase
J. Biol. Chem.,
January 10, 2003;
278(3):
1472 - 1479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cen, H. Javanbakht, S. Kim, K. Shiba, R. Craven, A. Rein, K. Ewalt, P. Schimmel, K. Musier-Forsyth, and L. Kleiman
Retrovirus-Specific Packaging of Aminoacyl-tRNA Synthetases with Cognate Primer tRNAs
J. Virol.,
November 13, 2002;
76(24):
13111 - 13115.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|